MAXIMUS, Inc. (NYSE:MMS) Vice Chairman Richard A. Montoni sold 44,002 shares of the business’s stock in a transaction on Thursday, September 20th. The shares were sold at an average price of $64.99, for a total value of $2,859,689.98. Following the completion of the sale, the insider now directly owns 493,476 shares in the company, valued at approximately $32,071,005.24. The sale was disclosed in a legal filing with the SEC, which is available through this link.
MAXIMUS stock traded up $0.38 on Friday, reaching $62.17. The company’s stock had a trading volume of 377,052 shares, compared to its average volume of 395,996. The firm has a market cap of $4.18 billion, a P/E ratio of 20.52, a P/E/G ratio of 2.51 and a beta of 1.12. MAXIMUS, Inc. has a twelve month low of $60.27 and a twelve month high of $72.71.
MAXIMUS (NYSE:MMS) last posted its quarterly earnings data on Thursday, August 9th. The health services provider reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.82 by $0.09. The company had revenue of $597.90 million for the quarter, compared to analyst estimates of $591.91 million. MAXIMUS had a return on equity of 21.51% and a net margin of 9.28%. The business’s revenue was down .4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.86 earnings per share. As a group, equities analysts forecast that MAXIMUS, Inc. will post 3.24 EPS for the current year.
MAXIMUS declared that its board has approved a share repurchase program on Monday, June 25th that allows the company to repurchase $200.00 million in outstanding shares. This repurchase authorization allows the health services provider to buy up to 4.9% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company’s board believes its shares are undervalued.
MMS has been the topic of several recent analyst reports. Zacks Investment Research raised MAXIMUS from a “sell” rating to a “hold” rating in a research note on Tuesday, August 14th. Canaccord Genuity boosted their price target on MAXIMUS from $64.00 to $67.00 and gave the company a “hold” rating in a research note on Wednesday.
A number of institutional investors have recently bought and sold shares of MMS. Cim LLC increased its holdings in MAXIMUS by 11.0% in the second quarter. Cim LLC now owns 8,050 shares of the health services provider’s stock valued at $500,000 after purchasing an additional 795 shares during the last quarter. Federated Investors Inc. PA increased its holdings in MAXIMUS by 3.7% in the first quarter. Federated Investors Inc. PA now owns 27,377 shares of the health services provider’s stock valued at $1,827,000 after purchasing an additional 987 shares during the last quarter. First Midwest Bank Trust Division increased its holdings in MAXIMUS by 13.2% in the second quarter. First Midwest Bank Trust Division now owns 8,674 shares of the health services provider’s stock valued at $539,000 after purchasing an additional 1,009 shares during the last quarter. BW Gestao de Investimentos Ltda. increased its holdings in MAXIMUS by 12.9% in the first quarter. BW Gestao de Investimentos Ltda. now owns 10,010 shares of the health services provider’s stock valued at $668,000 after purchasing an additional 1,141 shares during the last quarter. Finally, Keybank National Association OH increased its holdings in MAXIMUS by 5.8% in the second quarter. Keybank National Association OH now owns 21,525 shares of the health services provider’s stock valued at $1,337,000 after purchasing an additional 1,175 shares during the last quarter. 93.43% of the stock is currently owned by institutional investors.
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs in the United States, the United Kingdom, Australia, Canada, Singapore, and Saudi Arabia. The company's Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Preadmission Screening and Resident Reviews.
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.